Built upon the pillars of innovation, access, and connection, Generate has already helped grow and protect nearly 1 million families around the world.
Between life and science is opportunity.
While our companies make us the largest family-focused life sciences company in the world, it is our partnership with doctors, scientists, and parents that have made Generate the industry leader.
With 50% market share in the premium donor sperm market, California Cryobank has one of the most stringent qualification processes in the industry. The addition of Donor Egg Bank USA (in 2016), NW Cryobank, and Kitazato USA make Generate one of the largest reproductive services companies in the world.
Together they have helped create nearly 100,000 families and are fulfilling an increasing demand with the substantial growth of single parenting by choice, LGBTQ+ families, and couples having children later in life.
Since the company’s founding in 1992, CBR (Cord Blood Registry) has become the #1 newborn stem cell bank in the country. Constantly evolving and always at the forefront of technical innovations, CBR is dedicated to providing stem cell services that give families access to regenerative medicine treatments available today and in the future.
Powered by Sema4™, ReadyGen is an innovative and advanced pediatric screening test that empowers parents to further protect their children by delivering clinically actionable and personalized health insights. ReadyGen analyzes DNA for early detection and allows for early intervention of serious conditions that can affect children even before they have symptoms.
ReadyGen can also predict responses to 40+ medications that may be prescribed during childhood. This test helps a child’s physician choose medications tailored to a child’s unique genetic profile.
Kitazato USA by Generate Life Sciences is the exclusive distributor of Kitazato products in the US, offering a range of FDA compliant medical devices specially designed for the American market. Kitazato is the innovator of the advanced Cryotop® Method vitrification technique. After more than a decade on the market, the Cryotop® Method has been applied in over 1,500,000 clinical cases in over 90 countries and 2,200 assisted reproduction centers. Hundreds of scientific publications certify the Method’s impressive results.
Established in 2006, DonorApplication.com is used by fertility clinics to manage donor applications, donor eligibility, and recipient search/matching. Our product is specific to IVF clinics and donor agencies, assisting them in their efforts to recruit, screen, and match donors by providing software that automates the process.
Growing and protecting healthy families for 40+ years.
Have more questions? Please feel free to reach out for any additional information.